Ortho Clinical Diagnostics Holdings plc reported earnings results for the third quarter and nine months ended October 03, 2021. For the third quarter, the company reported sales was USD 522.5 million compared to USD 451.1 million a year ago. Net income was USD 14.7 million compared to net loss of USD 28.5 million a year ago. Basic earnings per share from continuing operations was USD 0.06 compared to basic loss per share from continuing operations of USD 0.2 a year ago. Diluted earnings per share from continuing operations was USD 0.06 compared to diluted loss per share from continuing operations of USD 0.2 a year ago. For the nine months, sales was USD 1,521.8 million compared to USD 1,249.6 million a year ago. Net loss was USD 44.4 million compared to USD 171 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 1.17 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 1.17 a year ago.